PF-06818883
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-06818883, covering 2017-12-11 to 2017-12-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of PF-06818883 in Healthy Subjects [Phase 1]